Nonsurgical interventions for Peyronie disease: 2011 update

Area of Science:

• Urology
• Andrology
• Regenerative Medicine

Background:

• Peyronie disease (PD) is characterized by collagen and fibrin plaque in the penile tunica albuginea.
• This plaque leads to penile induration and curvature, causing significant sexual dysfunction.
• Lack of awareness regarding PD pathophysiology and treatment options hinders timely medical intervention.

Purpose of the Study:

• To review recent literature (last 4 years) on emerging therapies for Peyronie disease.
• To identify and evaluate clinical trials for novel treatment modalities.
• To assess the evidence supporting new therapeutic approaches for PD.

Main Methods:

• Systematic literature review focusing on clinical trials published within the last four years.
• Analysis of studies evaluating oral pharmacotherapies, topical treatments, intralesional drug delivery, and shockwave therapy.
• Inclusion of research on penile traction devices as a treatment modality.

Main Results:

• The review synthesizes findings from recent clinical trials on various PD treatments.
• Evidence levels and support for oral, topical, intralesional, shockwave, and traction therapies are discussed.
• Emerging treatment strategies aim to alter the Peyronie disease process and improve outcomes.

Conclusions:

• Recent advancements offer new therapeutic avenues for Peyronie disease.
• Further research is needed to establish the efficacy and long-term benefits of novel treatments.
• Improved understanding and patient education are crucial for addressing PD and its impact on sexual health.